ASX:PKS

PKS Competitors

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

PKS (ASX:PKS) Vs. 1ST, ALC, BNVIF, CNNA, CNONF, and DOCRF

Should you be buying PKS stock or one of its competitors? Companies in the industry of "health information services" are considered alternatives and competitors to PKS, including 1st Group (1ST), Alcidion Group (ALC), Binovi Technologies (BNVIF), Cann American (CNNA), CannaOne Technologies (CNONF), and CloudMD Software & Services (DOCRF).

1st Group (ASX:1ST) and PKS (ASX:PKS) are both computer and technology companies, but which is the better business? We will compare the two companies based on the strength of their dividends, analyst recommendations, profitability, earnings, risk, institutional ownership and valuation.

Valuation and Earnings

This table compares 1st Group and PKS's gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
1st Group$5.11 million0.00$-4,246,169.92A($0.01)N/A
PKS$5.97 million0.00$436,638.02A$0.00N/A

PKS has higher revenue and earnings than 1st Group.

Profitability

This table compares 1st Group and PKS's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
1st GroupN/AN/AN/A
PKSN/AN/AN/A

Analyst Ratings

This is a summary of recent ratings and target prices for 1st Group and PKS, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
1st Group0000N/A
PKS0000N/A

Summary

PKS beats 1st Group on 3 of the 3 factors compared between the two stocks.

PKS (ASX:PKS) and Alcidion Group (ASX:ALC) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, risk, institutional ownership, profitability, earnings, dividends and valuation.

Profitability

This table compares PKS and Alcidion Group's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
PKSN/AN/AN/A
Alcidion GroupN/AN/AN/A

Analyst Ratings

This is a breakdown of recent recommendations for PKS and Alcidion Group, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
PKS0000N/A
Alcidion Group0000N/A

Valuation and Earnings

This table compares PKS and Alcidion Group's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
PKS$5.97 million0.00$436,638.02A$0.00N/A
Alcidion Group$21.55 million0.00$-2,972,082.05A$0.00N/A

PKS has higher earnings, but lower revenue than Alcidion Group.

Summary

PKS beats Alcidion Group on 2 of the 3 factors compared between the two stocks.

PKS (ASX:PKS) and Binovi Technologies (OTCMKTS:BNVIF) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, risk, analyst recommendations, valuation, institutional ownership, profitability and earnings.

Profitability

This table compares PKS and Binovi Technologies' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
PKSN/AN/AN/A
Binovi TechnologiesN/AN/AN/A

Analyst Recommendations

This is a breakdown of recent ratings for PKS and Binovi Technologies, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
PKS0000N/A
Binovi Technologies0000N/A

Valuation & Earnings

This table compares PKS and Binovi Technologies' revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
PKS$5.97 million0.00$436,638.02A$0.00N/A
Binovi TechnologiesN/AN/AN/AN/AN/A

PKS has higher revenue and earnings than Binovi Technologies.

Summary

PKS beats Binovi Technologies on 1 of the 1 factors compared between the two stocks.

Cann American (CNSX:CNNA) and PKS (ASX:PKS) are both computer and technology companies, but which is the better stock? We will contrast the two companies based on the strength of their profitability, valuation, risk, analyst recommendations, institutional ownership, earnings and dividends.

Profitability

This table compares Cann American and PKS's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Cann AmericanN/AN/AN/A
PKSN/AN/AN/A

Valuation and Earnings

This table compares Cann American and PKS's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cann AmericanN/AN/AN/AN/AN/A
PKS$5.97 million0.00$436,638.02A$0.00N/A

PKS has higher revenue and earnings than Cann American.

Analyst Recommendations

This is a summary of current ratings and target prices for Cann American and PKS, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Cann American0000N/A
PKS0000N/A

Summary

PKS beats Cann American on 1 of the 1 factors compared between the two stocks.

CannaOne Technologies (OTCMKTS:CNONF) and PKS (ASX:PKS) are both computer and technology companies, but which is the better stock? We will contrast the two companies based on the strength of their profitability, valuation, risk, analyst recommendations, institutional ownership, earnings and dividends.

Profitability

This table compares CannaOne Technologies and PKS's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
CannaOne TechnologiesN/AN/AN/A
PKSN/AN/AN/A

Valuation and Earnings

This table compares CannaOne Technologies and PKS's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CannaOne TechnologiesN/AN/AN/AN/AN/A
PKS$5.97 million0.00$436,638.02A$0.00N/A

PKS has higher revenue and earnings than CannaOne Technologies.

Analyst Recommendations

This is a summary of current ratings and target prices for CannaOne Technologies and PKS, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
CannaOne Technologies0000N/A
PKS0000N/A

Summary

PKS beats CannaOne Technologies on 1 of the 1 factors compared between the two stocks.

CloudMD Software & Services (OTCMKTS:DOCRF) and PKS (ASX:PKS) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, earnings, valuation, profitability, risk and dividends.

Analyst Ratings

This is a summary of current ratings and price targets for CloudMD Software & Services and PKS, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
CloudMD Software & Services00203.00
PKS0000N/A

CloudMD Software & Services currently has a consensus target price of $3.3750, indicating a potential upside of 110.28%.

Profitability

This table compares CloudMD Software & Services and PKS's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
CloudMD Software & ServicesN/AN/AN/A
PKSN/AN/AN/A

Valuation & Earnings

This table compares CloudMD Software & Services and PKS's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CloudMD Software & ServicesN/AN/AN/AN/AN/A
PKS$5.97 million0.00$436,638.02A$0.00N/A

PKS has higher revenue and earnings than CloudMD Software & Services.


PKS Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
1st Group logo
1ST
1st Group
0.5N/AN/A$0.00$5.11 million0.00High Trading Volume
Gap Up
ALC
Alcidion Group
0.5N/AN/A$0.00$21.55 million0.00High Trading Volume
Gap Up
Binovi Technologies logo
BNVIF
Binovi Technologies
0.0$0.06flat$0.00N/A0.00Gap Down
CNNA
Cann American
0.5N/AN/A$0.00N/A0.00High Trading Volume
CannaOne Technologies logo
CNONF
CannaOne Technologies
0.6$1.01flat$0.00N/A0.00Decrease in Short Interest
CloudMD Software & Services logo
DOCRF
CloudMD Software & Services
1.7$1.61flat$0.00N/A0.00Gap Up
DOC
CloudMD Software & Services
1.2$2.01flatC$0.00C$11.65 million-22.33
CGS
Cogstate
0.5N/AN/A$0.00$28.82 million0.00High Trading Volume
Gap Up
COO
Corum Group
0.5N/AN/A$0.00$12.27 million0.00High Trading Volume
EGF Theramed Health logo
EVAHF
EGF Theramed Health
0.0$0.11flat$0.00N/A0.00Gap Down
EMD
Emyria
0.6N/AN/A$0.00$1.73 million0.00High Trading Volume
Gap Up
EWLL
eWellness Healthcare
0.6$0.00flat$0.00N/A0.00
FORA
Forian
0.3$12.05flat$0.00N/A0.00
GLH
Global Health
0.5N/AN/A$0.00$6.77 million0.00High Trading Volume
Gap Up
ICS
ICS Global
0.9N/AN/A$0.00$6.08 million0.00High Trading Volume
Gap Up
JHL
Jayex Healthcare
0.7N/AN/A$0.00$6.61 million0.00High Trading Volume
Gap Up
M3 logo
MTHRF
M3
1.0$76.00flat$0.00N/A0.00
M7T
Mach7 Technologies
0.6N/AN/A$0.00$16.89 million0.00High Trading Volume
Gap Up
MDR
MedAdvisor
0.5N/AN/A$0.00$18.09 million0.00High Trading Volume
Gap Up
NEWUF
Newtopia
1.7$0.41flat$0.00N/A0.00Gap Up
NHL
Novita Healthcare
0.5N/AN/A$0.00N/A0.00High Trading Volume
Gap Up
ONE
Oneview Healthcare
0.5N/AN/A$0.00$7.10 million0.00High Trading Volume
OPL
Opyl
0.0N/AN/A$0.00$741,494.000.00High Trading Volume
PCK
PainChek
0.0N/AN/A$0.00$240,424.000.00High Trading Volume
PANHF
Ping An Healthcare and Technology
1.0$12.20flat$0.00N/A0.00
PME
Pro Medicus
0.7N/AN/A$0.00$59.12 million0.00High Trading Volume
Gap Up
Pro Medicus logo
PMCUF
Pro Medicus
0.5$35.65flat$0.00N/A0.00
RAP
ResApp Health
0.9N/AN/A$0.00$46,197.000.00High Trading Volume
Gap Up
CBIIF
Skylight Health Group
0.0$0.73flat$0.00N/A0.00High Trading Volume
Gap Down
TD1
TALi Digital
0.5N/AN/A$0.00$706,550.000.00High Trading Volume
UCBB
US-China Biomedical Technology
0.3$0.13flat$0.00N/A0.00Gap Down
WELL Health Technologies logo
WLYYF
WELL Health Technologies
1.6$5.88flat$0.00N/A0.00
ZMD
ZoomMed
0.4$0.02flatC$0.00C$10,000.00-1.36Gap Down
This page was last updated on 4/19/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.